Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12070466 D

Patent 12070466 was granted and assigned to Sydnexis on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kenneth J. Widder0

Gregory I. Ostrow0

David S. Baker0

Date of Patent

August 27, 2024

0

Patent Application Number

173354960

Date Filed

June 1, 2021

0

Patent Citations

US Patent 8404271 Contact drug delivery system

0

US Patent 7691099 Deuterated ocular solutions for LTK and other surgical eye procedures

0

US Patent 7858582 Ophthalmic hGM-CSF preparation

0

US Patent 8333985 Non-glycerol stabilized bone graft

0

US Patent 10251875 Atropine pharmaceutical compositions

0

US Patent 10813923 Ophthalmic composition

0

US Patent 10842787 Ophthalmic composition

0

US Patent 10864208 Ophthalmic composition

0

...

Patent Primary Examiner

Genevieve S Alley

0

CPC Code

0

0

0

Patent abstract

Provided herein is an ophthalmic composition formulated in deuterated water. Also disclosed herein are methods of treating, ameliorating, or reducing ophthalmic conditions or diseases by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12070466 D

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool